Monobe Y, Manabe T
Department of Pathology, Kawasaki Medical School, Kurashiki, Japan.
Virchows Arch. 1995;425(6):583-8. doi: 10.1007/BF00199346.
We have observed sequential cellular changes in type II pneumocytes in mouse lungs following oral administration of 0.1% urethan solution. Histologically, scatterings of swollen alveolar cells were first noticed 25 days after administration. These cells continued to swell further, after which they aggregated more compactly to form a papillary structure by day 75. After day 100, distinct tumour nodules were found with atypical large cells in some areas. Necrotic foci appeared in large tumours of more than 4 mm diameter. At day 250, nucleoli became distinct and large bizarre and multinucleated cells were intermingled with some mitotic figures. These morphologies correspond to conventional descriptions; that is, hyperplasia (day 25-75), benign neoplastic changes (day 75-100) and malignant neoplastic changes (day 100-250). The proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (AgNOR) scores in these lesions increased with time, and proliferative activities during tumour progression seemed continuous. However, proliferative activity of the cells on specific days did not differ statistically from the values on neighboring days. We speculate that the hyperplasia-like lesions seen in our mice are neoplastic in nature from their outset.
我们观察了给小鼠口服0.1%乌拉坦溶液后II型肺细胞的一系列细胞变化。组织学上,给药后25天首次注意到肺泡细胞肿胀散在分布。这些细胞继续进一步肿胀,之后到75天时它们更紧密地聚集形成乳头状结构。100天后,在一些区域发现有明显的肿瘤结节,伴有非典型大细胞。直径超过4mm的大肿瘤中出现坏死灶。在250天时,核仁变得明显且大,奇异的多核细胞与一些有丝分裂象混合存在。这些形态与传统描述相符,即增生(25 - 75天)、良性肿瘤性改变(75 - 100天)和恶性肿瘤性改变(100 - 250天)。这些病变中增殖细胞核抗原(PCNA)和核仁组织区(AgNOR)评分随时间增加,肿瘤进展过程中的增殖活性似乎是持续的。然而,特定天数细胞的增殖活性与相邻天数的值在统计学上没有差异。我们推测在我们的小鼠中看到的增生样病变从一开始在本质上就是肿瘤性的。